Gennex Laboratories Quarterly Results for Trading Insights
GENNEX • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹6 Cr
QSept 2025
Gennex Laboratories Quarterly Results Key Highlights
- Revenue of ₹39 Cr in Sept 2025 (-11.4% vs Mar 2025, +21.9% vs Sept 2024)
- Net Profit of ₹6 Cr in Sept 2025 (+100.0% vs Mar 2025, +20.0% vs Sept 2024)
- EBITDA of ₹8 Cr in Sept 2025 (+33.3% vs Mar 2025)
- Operating Margin of 15.0% in Sept 2025 (+10.0pp vs Mar 2025)
- Earnings Per Share of ₹0.21 in Sept 2025 (+50.0% vs Mar 2025)
Gennex Laboratories Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 39 | 44 | 37 | 32 | 34 | -11.4% | 21.9% |
| Net Profit (₹ Cr) | 6 | 3 | 5 | 5 | 5 | - | - |
| EBITDA (₹ Cr) | 8 | 6 | 7 | 6 | 4 | - | - |
| EPS (₹) | 0.21 | 0.14 | 0.22 | 0.21 | 0.16 | - | - |
| Operating Margin (%) | 15.0% | 5.0% | 15.0% | 18.0% | 13.0% | - | - |
Gennex Laboratories Share Price Trend Around Quarterly Results
Visualize Gennex Laboratories's 1-year price movement across quarterly results — ideal for logging trades in Gennex Laboratories share price
chart using Tickjournal. All values in ₹.
Related Pages for Gennex Laboratories
Additional stock information and data for GENNEX
Revenue Trend (₹ Cr)
Sept 2024
32
Jun 2025
37
Mar 2025
44
Sept 2025
39
Net Profit Trend (₹ Cr)
Sept 2024
5
Jun 2025
5
Mar 2025
3
Sept 2025
6
Operating Margin Trend (%)
Sept 2024
18.0%
Jun 2025
15.0%
Mar 2025
5.0%
Sept 2025
15.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Gennex Laboratories quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹422,330.94 Cr | 1782.6 | 14,875 | 3,125 | +10.8% | - | 21.0% | 137.1 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6642.5 | 2,860 | 689 | +7.1% | - | 24.1% | 255.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 4092.2 | 3,219 | 591 | +11.3% | - | 18.4% | 233.3 |
|
Cipla
Sept 2025 |
₹121,238.47 Cr | 1467.9 | 7,716 | 1,353 | +12.0% | - | 17.5% | 87.7 |
|
Dr Reddys Laborator…
Sept 2025 |
₹104,829.57 Cr | 1242.8 | 9,135 | 1,337 | +1.1% | - | 14.6% | 76.8 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores